Skip to main content

Table 3 Treatment related toxicities (CTCAE version 4.0)

From: Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience

 

G1/G2

G3/G4

Intratumoral bleeding

-

1 (7%)

Haemoperitoneum

-

1 (7%)

Multiple kidney infarct

-

1 (7%)

Skin reactions

5 (38%)

1 (7%)

Fatigue

10 (77%)

-

Diarrhoea

5 (38%)

-

Dysgeusia

4 (31%)

-

Nausea

3 (24%)

-

Mucositis

3 (24%)

-

Anorexia

3 (24%)

-

Liver function test alteration

2 (15%)

-

Neutropenia

1 (7%)

-